Home » Topics » BioWorld Science

BioWorld Science
RSS

Atypical antipsychotic receives approvals

Oct. 4, 1996

Genset and Johnson & Johnson collaborate in the area of schizophrenia

Oct. 4, 1996

New antipsychotic agents from Janssen

Oct. 4, 1996

5-HT2B/2C antagonists disclosed by SKB

Oct. 4, 1996

Novel benzodiazepine derivatives from Roche

Oct. 4, 1996

Introduction of integrated test for breast and ovarian cancer ahead of schedule

Oct. 4, 1996

Antex awarded SBIR grant for diagnostic tests

Oct. 4, 1996

Broad patent coverage for Sonus's ultrasound contrast agents

Oct. 4, 1996

Promising clinical results with gastrointestinal cancer diagnostic

Oct. 4, 1996

Japanese licensing agreement for Geron's telomerase detection technology

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...